Please select the option that best describes you:
Topics:
Gynecologic Cancers • Ovarian Cancer
In a patient with an HR-proficient stage III high-grade serous ovarian cancer s/p R0 primary debulking surgery for whom you are not considering bevacizumab in addition to chemotherapy, would you consider IP chemotherapy?
Why or why not?
For what patient population(s), if any, are you recommending IP chemotherapy?